BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33883903)

  • 1. Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.
    Hu P; Ben Y; Liu J; Zheng W; Yan X; Zhang Y; Shi W
    Onco Targets Ther; 2021; 14():2489-2495. PubMed ID: 33883903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma.
    Hashimoto A; Asai S; Tanaka Y; Shinzato I
    Eur J Case Rep Intern Med; 2021; 8(10):002533. PubMed ID: 34790617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus positive diffuse large B-cell lymphoma transformed into angioimmunoblastic T-cell lymphoma after treatment.
    Wang C; Gong Y; Jiang Q; Liang X; Chen R
    Clin Case Rep; 2021 May; 9(5):e04083. PubMed ID: 34084501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma.
    Zhou Y; Rosenblum MK; Dogan A; Jungbluth AA; Chiu A
    J Hematop; 2015 Dec; 8(4):235-241. PubMed ID: 27559423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenalidomide combined with R-GDP in a patient with refractory CD5-positive diffuse large B-cell lymphoma: A promising response and review.
    Zhang Y; Wang X; Liu Y; Sun C; Shi W; Huang H
    Cancer Biol Ther; 2018 Jul; 19(7):549-553. PubMed ID: 29611764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified.
    Hoffmann JC; Chisholm KM; Cherry A; Chen J; Arber DA; Natkunam Y; Warnke RA; Ohgami RS
    Hum Pathol; 2016 Feb; 48():9-17. PubMed ID: 26772393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
    Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide.
    Kishimoto W; Takiuchi Y; Nakae Y; Tabata S; Fukunaga A; Matsuzaki N; Yuba Y; Kitano T; Arima N
    Int J Hematol; 2019 Apr; 109(4):499-504. PubMed ID: 30604313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.
    Attygalle AD; Kyriakou C; Dupuis J; Grogg KL; Diss TC; Wotherspoon AC; Chuang SS; Cabeçadas J; Isaacson PG; Du MQ; Gaulard P; Dogan A
    Am J Surg Pathol; 2007 Jul; 31(7):1077-88. PubMed ID: 17592275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
    Huang J; Zhang PH; Gao YH; Qiu LG
    Diagn Cytopathol; 2012 Apr; 40(4):346-51. PubMed ID: 21472868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
    Takahashi T; Maruyama R; Mishima S; Inoue M; Kawakami K; Onishi C; Miyake T; Tanaka J; Nabika T; Ishikura H
    J Clin Exp Hematop; 2010; 50(1):59-63. PubMed ID: 20505277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-positive, CD30-positive, diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
    Grossman M; Ruan J; Magro C
    JAAD Case Rep; 2022 Jul; 25():58-62. PubMed ID: 35755174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Discordant lymphoma of duodenal EBV-positive peripheral T-cell lymphoma not otherwise specified and ileal diffuse large B-cell lymphoma].
    Kurihara T; Sumi M; Kaiume H; Takeda W; Kirihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Asano N; Watanabe M; Kobayashi H
    Rinsho Ketsueki; 2016 Apr; 57(4):445-50. PubMed ID: 27169448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
    Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: a case report.
    Chams S; Hajj Hussein I; El Sayegh S; Chams N; Zakaria K
    J Med Case Rep; 2018 Apr; 12(1):101. PubMed ID: 29673407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma.
    Zhang F; Li W; Cui Q; Chen Y; Liu Y
    Front Genet; 2022; 13():940513. PubMed ID: 35938041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL).
    Bahri R; Boyer F; Halabi MA; Chaunavel A; Feuillard J; Jaccard A; Ranger-Rogez S
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanctuary site central nervous system relapse-refractory DLBCL responding to nivolumab and lenalidomide.
    Madabhavi IV; Revannasiddaiah S; Sarkar MS; Modi MG
    Oral Oncol; 2019 Jun; 93():122-124. PubMed ID: 31010638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
    Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
    Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.
    Witte HM; Merz H; Biersack H; Bernard V; Riecke A; Gebauer J; Lehnert H; von Bubnoff N; Feller AC; Gebauer N
    Br J Haematol; 2020 Apr; 189(2):257-268. PubMed ID: 31958882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.